US20080026428A1 - Method for producing nucleotide by fermentation - Google Patents

Method for producing nucleotide by fermentation Download PDF

Info

Publication number
US20080026428A1
US20080026428A1 US11/838,109 US83810907A US2008026428A1 US 20080026428 A1 US20080026428 A1 US 20080026428A1 US 83810907 A US83810907 A US 83810907A US 2008026428 A1 US2008026428 A1 US 2008026428A1
Authority
US
United States
Prior art keywords
gene
nucleoside
phosphate ester
strain
usha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/838,109
Inventor
Masahiro Kakehi
Yoshihiro Usuda
Yukiko Tabira
Shinichi Sugimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to US11/838,109 priority Critical patent/US20080026428A1/en
Publication of US20080026428A1 publication Critical patent/US20080026428A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/32—Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide

Definitions

  • the present invention relates to a method for producing nucleotides by fermentation.
  • Nucleotides such as nucleoside 5′-phosphate esters are useful as seasonings, drugs, raw materials thereof and so forth.
  • nucleoside 5′-phosphate esters As methods for industrial production of nucleoside 5′-phosphate esters, there are known methods comprising producing nucleoside by fermentation and enzymatically phosphorylating the obtained nucleoside to obtain nucleoside 5′-phosphate ester.
  • Japanese Patent Publication (Kokoku) No. 56-12438 discloses a method for producing 5′-guanylic acid, which comprises culturing a mutant strain of a bacterium belonging to the genus Bacillus showing adenine auxotrophy and resistance to decoyinine or methionine sulfoxide and having an ability to produce 5′-guanylic acid (guanosine 5′-monophosphate, also abbreviated as “GMP” hereinafter) and collecting GMP produced and accumulated in the medium.
  • GMP guanosine 5′-monophosphate
  • nucleoside 5′-phosphate esters As described above, various studies have been made on the production of nucleoside 5′-phosphate esters by direct fermentation, and some successful examples are also known. However, there are many unknown points about nucleotide degradative enzymes, and it cannot be said that improvement of yield has been studied sufficiently. In particular, no example of production of nucleoside 5′-phosphate esters on a practical level has been known for bacteria belonging to the genus Escherichia.
  • the present invention was accomplished in view of the technical situation described above, and an object of the invention is to provide a method for producing nucleoside 5′-phosphate ester such as IMP using a bacterium belonging to the genus Escherichia.
  • the inventors of the present invention assiduously studied in order to achieve the aforementioned object. As a result, they found that a gene coding for 5′-nucleotidase other than the known gene existed in Escherichia coli, and successfully identified the gene. Further, they found that Escherichia coli having inosine producing ability or guanosine producing ability became to produce IMP or GMP, if the novel gene was disrupted in addition to the known 5′-nucleotidase gene. Thus, they accomplished the present invention.
  • the present invention provides the followings.
  • a method for producing nucleoside 5′-phosphate ester comprising the steps of culturing a bacterium belonging to the genus Escherichia having an ability to produce nucleoside 5′-phosphate ester, in which ushA gene and aphA gene do not function normally, in a medium to produce and accumulate nucleoside 5′-phosphate ester in the medium, and collecting the nucleoside 5′-phosphate ester from the medium.
  • nucleoside 5′-phosphate ester according to (1) or (2), wherein the nucleoside 5′-phosphate ester is selected from the group consisting of 5′-inosinic acid or 5′-guanylic acid.
  • nucleoside 5′-phosphate ester is selected from the group consisting of 5′-inosinic acid or 5′-guanylic acid.
  • a method for searching for a 5′-nucleotidase gene affecting accumulation of nucleoside 5′-phosphate ester comprising the steps of culturing a parent strain of microorganism and a derivative strain thereof in which a known 5′-nucleotidase is deleted in a minimal medium containing a first nucleoside 5′-phosphate ester as a sole carbon source and a minimal medium containing a second nucleoside 5′-phosphate ester as a sole carbon source to examine expression profiles of genes in the parent strain and the derivative strain,
  • nucleoside 5′-phosphate ester such as IMP and GMP can be produced by direct fermentation using a bacterium belonging to the genus Escherichia.
  • UDP-sugar hydrolase As a known 5′-nucleotidase of Escherichia coli, UDP-sugar hydrolase (UshA), which is a product of the ushA gene (GenBank accession X03895), is known. It has been known that the enzyme has 5′-nucleotidase activity that catalyzes dephosphorylation of nucleoside 5′-phosphate such as AMP, GMP, IMP and XMP to produce a corresponding nucleoside (H. C. Neu, (1967) Journal of Biological Chemistry, 242, 3896-3904; A. Cowman, I. R. Beacham, (1980) Gene, 12, 281-286).
  • UshA UDP-sugar hydrolase
  • the inventors of the present invention disrupted the ushA gene of Escherichia coli W3110 strain, and examined its influence on the nucleotide decomposing ability.
  • the 5′-nucleotidase activity in periplasm of the ushA gene-disrupted W3110 strain (W ⁇ ushA) was markedly reduced compared with the W3110 strain.
  • W ⁇ ushA 5′-nucleotidase activity in periplasm of the ushA gene-disrupted W3110 strain
  • this strain could grow. Therefore, it was considered that the nucleotide decomposing ability is not completely lost by the disruption of only ushA.
  • nucleoside-5′-phosphate was used as a sole carbon source, start of the growth was retarded. Therefore, it was expected that there existed another 5′-nucleotidase that was induced when UshA did not function.
  • the inventor of the present invention attempted to search for an unknown 5′-nucleotidase gene based on the aforementioned findings, and found that a product of a gene reported as an acid phosphatase gene (aphA) (M. C. Thaller, S. Schippa, A. Bonci, S. Cresti, G. M. Rossolini, (1997) FEMS Microbilogy Letters, 146, 191-198, GenBank accession X86971) or yjbP (GenBank accession AAC77025) had the 5′-nucleotidase activity.
  • aphA acid phosphatase gene reported as an acid phosphatase gene (aphA) (M. C. Thaller, S. Schippa, A. Bonci, S. Cresti, G. M. Rossolini, (1997) FEMS Microbilogy Letters, 146, 191-198, GenBank accession X86971) or yjbP (GenBank accession A
  • a gene coding for such a 5′-nucleotidase that affects the accumulation of nucleoside 5′-phosphate as described above can be searched for as follows.
  • a microbial parent strain and a derivative strain thereof in which a known 5′-nucleotidase is deleted are cultured in a minimal medium containing a first nucleoside 5′-phosphate ester or a second nucleoside 5′-phosphate ester such as IMP or GMP as a sole carbon source.
  • a first nucleoside 5′-phosphate ester or a second nucleoside 5′-phosphate ester such as IMP or GMP as a sole carbon source.
  • the known 5′-nucleotidase may be the aforementioned UshA.
  • a product of a ratio of expression amounts of a gene in the parent strain and the derivative strain when they are cultured in a medium containing the first nucleoside 5′-phosphate as a carbon source and a ratio of expression amounts of the gene in the parent strain and the derivative strain when they are cultured in a medium containing the second nucleoside 5′-phosphate as a carbon source is calculated for each gene, and one or more genes showing a larger value of the product are selected.
  • the method for gene expression profiling is not particularly limited, the DNA array method (H. Tao, C. Bausch, C. Richmond, F. R. Blattner, T. Conway, (1999) Journal of Bacteriology, 181, 6425-6440) can be mentioned, for example.
  • target genes can be further narrowed down by selecting genes that may code a signal sequence required for transition of protein to periplasm. This is because it is expected that the target 5′-nucleotidase transits to periplasm and function therein.
  • b0220 As for Escherichia coli, as shown in the examples mentioned later, two kinds of genes, b0220 (also referred to as o157) and yjbP, were selected. Among these genes, yjbP was an acid phosphatase gene (aphA). On the other hand, b0220 was a gene of which function was unidentified, which was designated as ykfE. When these genes were amplified in Escherichia coli, remarkable increase of 5′-nucleotidase activity was not observed in the ykfE gene-amplified strain, whereas remarkable increase of 5′-nucleotidase activity was observed in the aphA gene-amplified strain.
  • aphA acid phosphatase gene
  • aphA gene product (AphA) had the 5′-nucleotidase activity.
  • aphA was found as a gene coding for 5′-nucleotidase that affected the accumulation of nucleoside 5′-phosphate.
  • the Bacterium belonging to the genus Escherichia of the present invention is a bacterium belonging to the genus Escherichia having an ability to produce nucleoside 5′-phosphate, in which the ushA gene and the aphA gene do not function normally.
  • the Bacterium belonging to the genus Escherichia itself is not particularly limited so long as it is a microorganism belonging to the genus Escherichia such as Escherichia coli.
  • those mentioned in the reference of Neidhardt et al. Neidhardt, F. C. et al., Escherichia coli and Salmonella Typhimurium, American society for Microbiology, Washington D.C., 1208, Table 1 can be used.
  • the Bacterium belonging to the genus Escherichia of the present invention can be obtained by, for example, breeding a mutant strain or genetic recombinant strain in which the ushA gene and the aphA gene do not normally function using a Bacterium belonging to the genus Escherichia having purine nucleoside producing ability as a parent strain. Further, the Bacterium belonging to the genus Escherichia of the present invention can also be obtained by breeding similar to the breeding of purine nucleoside producing strain using a strain in which the ushA gene and the aphA gene do not normally function as a parent strain.
  • bacteria belonging to the genus Escherichia having purine nucleoside producing ability include bacteria belonging to the genus Escherichia having an ability to produce inosine, guanosine, adenosine, xanthosine, purine riboside, 6-methoxypurine riboside, 2,6-diaminopurine riboside, 6-fluoropurine riboside, 6-thiopurine riboside, 2-amino-6-thiopurine riboside, mercaptoguanosine or the like.
  • bacteria belonging to the genus Escherichia having an ability to produce nucleoside 5′-phosphate ester corresponding to each purine nucleoside can be obtained.
  • the purine nucleoside producing ability referred to in the present invention means an ability to produce and accumulate a purine nucleoside in a medium. Further, the expression of “having purine nucleoside producing ability” means that the microorganism belonging to the genus Escherichia produces and accumulates a purine nucleoside in a medium in an amount larger than that obtained with a wild strain of E. coli, for example, the W3110 strain.
  • the ability to produce nucleoside 5′-phosphate ester means an ability to produce and accumulate nucleoside 5′-phosphate ester in a medium.
  • the expression of “having purine nucleoside producing ability” means that the microorganism belonging to the genus Escherichia produces and accumulates a purine nucleoside in a medium in an amount larger than that obtained with a wild strain of E. coli, for example, the W3110 strain, and it preferably means that the microorganism produces and accumulates nucleoside 5′-phosphate ester in an amount of 100 mg/L or more, more preferably 500 mg/L or more, further preferably 1000 mg/L or more, when it is cultured under the conditions mentioned in Example 6 described later.
  • Bacteria belonging to the genus Escherichia having purine nucleoside producing ability are detailed in International Patent Publication WO99/03988, for example. More specifically, there can be mentioned the Escherichia coli FADRaddG-8-3::KQ strain (purFKQ, purA ⁇ , deoD ⁇ , purR ⁇ , add ⁇ , gsk ⁇ ) described in the above international patent publication.
  • This strain harbors a mutant purF coding for PRPP amidotransferase of which feedback inhibition by AMP and GMP is desensityzed, and in which the lysine residue at a position of 326 is replaced with a glutamine residue, and a succinyl-AMP synthase gene (purA), purine nucleoside phosphorylase gene (deoD), purine repressor gene (purR), adenosine deaminase gene (add), and inosine/guanosine kinase gene (gsk) are disrupted.
  • This strain given with a private number of AJ13334 was deposited on Jun.
  • the strain obtained by introducing a plasmid containing a mutant purF gene into the FADRaddeddyicPpgixapA strain can also be suitably used as an inosine producing bacterium.
  • Guanosine producing ability can be enhanced by introducing the guaA and guaB genes that encode IMP dehydrogenase and GMP synthetase, respectively, into an inosine producing bacterium.
  • the bacterial strain is not limited to the aforementioned strains, and any strains having purine nucleoside producing ability can be used without any particular limitation.
  • a mutant strain or genetic recombinant strain in which the ushA gene and the aphA gene do not function normally can be obtained by modifying the genes so that the activities of 5′-nucleotidases that are the products of the genes should be decreased or deleted, or transcription of these genes should be decreased or eliminated.
  • Such a microorganism can be obtained by, for example, replacing the ushA gene and the aphA gene on the chromosome with an ushA gene and aphA gene that do not function normally (also referred to as “disrupted ushA gene” and “disrupted aphA gene” hereinafter) by homologous recombination utilizing a genetic recombination method (Experiments in Molecular Genetics, Cold Spring Harbor Laboratory press (1972); Matsuyama, S. and Mizushima, S., J. Bacteriol., 162, 1196 (1985)).
  • a plasmid or the like having a sequence showing homology to a sequence on a chromosome is introduced into a bacterial cell. Then, recombination occurs at a certain frequency at a position of the homologous sequence so that the whole introduced plasmid is incorporated into the chromosome.
  • the plasmid is again removed from the chromosome. At this time, depending on the position of the recombination, the disrupted gene may remain on the chromosome, and the original normal gene may be removed together with the plasmid.
  • a gene disruption technique based on such homologous recombination has already been established, and a method utilizing a linear DNA, a method utilizing a temperature sensitive plasmid and so forth can be used.
  • the disruption of the ushA gene and the aphA gene can also be performed by using a plasmid containing an ushA gene or aphA gene internally inserted with a marker gene such as a drug resistance gene, which cannot replicate in a target microbial cell. That is, in a transformant that was transformed with the aforementioned plasmid and hence acquired drug resistance, the marker gene is incorporated into the chromosomal DNA.
  • this marker gene is incorporated into the chromosome by homologous recombination of the ushA gene or aphA gene sequences located on the both ends of the marker gene with those genes on the chromosome, a gene-disrupted strain can be selected efficiently.
  • the disrupted ushA gene and the disrupted aphA gene used for the gene disruption can be obtained by, specifically, deleting a certain region of these genes by digestion with a restriction enzyme and ligation, inserting another DNA fragment (marker gene etc.) into these genes, or introducing substitution, deletion, insertion, addition or inversion of one or more nucleotides into a nucleotide sequence of coding region, promoter region or the like of the ushA gene or the aphA gene by the site-specific mutagenesis (Kramer, W. and Frits, H.
  • the method of deleting a certain region of the ushA gene or aphA by digestion with a restriction enzyme and ligation and the method of inserting another DNA fragment into these genes are preferred in view of certainty and stability of the methods.
  • the order of the gene disruption of the ushA gene and the aphA gene is not particularly limited, and either one may be disrupted first.
  • the nucleotide sequences of the ushA gene and the aphA genes themselves are known, and hence they can be easily obtained by PCR or hybridization based on such nucleotide sequences.
  • the ushA gene can be obtained from chromosome DNA of Escherichia coli by PCR using the primers shown in SEQ ID NOS: 1 and 2, for example.
  • the N-terminal region of the aphA gene can be obtained by PCR using the primers shown in SEQ ID NOS: 3 and 7, and the C-terminal region of the same can be obtained by PCR using the primers shown in SEQ ID NOS: 4 and 8.
  • Whether the target gene has been disrupted or not can be confirmed by analyzing the gene on a chromosome by Southern blotting or PCR.
  • Nucleoside 5′-phosphate ester can be produced by culturing a bacterium belonging to the genus Escherichia having an ability to produce nucleoside 5′-phosphate ester, in which the ushA gene and the aphA gene do not function normally, in a medium to produce and accumulate nucleoside 5′-phosphate ester in the medium, and collecting the nucleoside 5′-phosphate ester from the medium.
  • the medium may be a usual medium containing a carbon source, nitrogen source, inorganic ions, and other organic components, if needed.
  • a carbon source there can be used saccharides such as glucose, lactose, galactose, fructose, arabinose, maltose, xylose, trehalose, ribose and starch hydrolysate, alcohols such as glycerol, mannitol and sorbitol, organic acids such as gluconic acid, fumaric acid, citric acid and succinic acid and so forth.
  • the nitrogen source there can be used inorganic ammonium salts such as ammonium sulfate, ammonium chloride, and ammonium phosphate, organic nitrogen such as soybean hydrolysate, ammonia gas, aqueous ammonia and so forth.
  • inorganic ammonium salts such as ammonium sulfate, ammonium chloride, and ammonium phosphate
  • organic nitrogen such as soybean hydrolysate, ammonia gas, aqueous ammonia and so forth.
  • organic trace nutrients it is desirable to add required substances including vitamins such as vitamin B1, nucleic acids such as adenine and RNA or yeast extract in a suitable amount.
  • required substances including vitamins such as vitamin B1, nucleic acids such as adenine and RNA or yeast extract.
  • a small amount of potassium phosphate, magnesium sulfate, iron ions, manganese ions and so forth are added as required.
  • Culture is preferably carried out under an aerobic condition for 16-72 hours.
  • the culture temperature is controlled to be 30° C. to 45° C.
  • pH is controlled to be 5 to 8 during the culture.
  • Inorganic or organic, acidic or alkaline substances as well as ammonia gas and so forth can be used for pH adjustment.
  • Collection of nucleoside 5′-phosphate ester from fermented liquor is usually carried out by a combination of an ion exchange resin method, a precipitation method and other known techniques.
  • a ushA gene fragment was amplified by PCR.
  • the genomic DNA was extracted by using RNA/DNA maxi Kit (produced by Qiagen).
  • PCR was performed by using the primers shown in SEQ ID NOS: 1 and 2 and Pyrobest DNA Polymerase (produced by Takara Shuzo) according to the instruction appended to the polymerase.
  • the amplified DNA fragments were purified by using Wizard PCR Preps (produced by Promega). After digestion with restriction enzymes SphI and SalI (produced by Takara Shuzo), the purified DNA fragments were subjected to a phenol/chloroform treatment and ethanol precipitation.
  • pHSG397 (produced by Takara Shuzo) similarly digested with SphI and SalI was ligated by using DNA ligation Kit Ver.2 (produced by Takara Shuzo). Competent cells of JM109 (produced by Takara Shuzo) were transformed with the above ligation mixture, and plated on an LB agar plate containing 30 ⁇ g/mL of chloramphenicol (produced by Sigma) (LB+chloramphenicol plate). After culturing at 37° C. overnight, grown colonies were cultured in LB medium containing 30 ⁇ g/mL of chloramphenicol at 37° C. in a test tube, and a plasmid was extracted using an automatic plasmid extractor, PI-50 (produced by Kurabo Industries). The obtained plasmid was designated as pHSGushA.
  • pHSGushA was digested with a restriction enzyme HpaI (produced by Takara Shuzo), subjected to a phenol/chloroform treatment and ethanol precipitation, and ligated by using DNA Ligation Kit Ver.2. JM109 was transformed with this ligation solution, and a plasmid was extracted from emerged colonies. The obtained plasmid was digested with SphI and SalI, and subjected to agarose gel electrophoresis to select a plasmid containing an inserted target fragment in which the HpaI digestion fragment was deleted from the ushA gene region.
  • HpaI produced by Takara Shuzo
  • the obtained plasmid fragment and a fragment obtained by digesting the temperature sensitive plasmid pMAN997 described in International Patent Publication WO99/03988 with SphI and SalI were ligated.
  • JM109 was transformed with the ligation solution, and colonies were selected at 30° C. on an LB agar plate containing 50 ⁇ g/mL of ampicillin (produced by Meiji Seika Kaisha) (LB+ampicillin plate). The colonies were cultured in LB medium containing 50 ⁇ g/mL of ampicillin at 30° C. in a test tube, and plasmids were extracted.
  • a plasmid from which a fragment of a desired length could be obtained by digestion with SphI and SalI was used as a plasmid for ushA disruption, pMAN ⁇ ushA.
  • the above pMAN997 was obtained by exchanging VspI-HindIII fragments of pMAN031 (J. Bacteriol., 162, 1196 (1985)) and pUC19 (produced by Takara Shuzo).
  • the W3110 strain was transformed with pMAN ⁇ ushA, and colonies were selected on an LB+ampicillin plate at 30° C.
  • the selected clones were cultured at 30° C. overnight as liquid culture.
  • the culture broth was diluted 10 ⁇ 3 times, and inoculated on an LB+ampicillin plate, and colonies were selected at 42° C.
  • the selected clones were applied and spread on an LB+ampicillin plate, and cultured at 30° C. Then, 1 ⁇ 8 of the cells on the plate were suspended in 2 mL of LB medium, and cultured at 42° C. for 4 to 5 hours with shaking.
  • the cells diluted 10 ⁇ 5 times were seeded on an LB plate, and several hundreds of colonies among the obtained colonies were inoculated on an LB plate and LB+ampicillin plate, and growth was confirmed to select ampicillin sensitive strains. Colony PCR was performed for several strains among the ampicillin sensitive strains to confirm the deletion of ushA gene. In this way, an ushA-disrupted strain derived from E. coli W3110, W ⁇ ushA, was obtained.
  • W3110 and W ⁇ ushA were cultured at 37° C. in LB medium, and periplasm was extracted from cells in a proliferation phase according to the method of Edwards et al. (C. J. Edwards, D. J. Innes, D. M. Burns, I. R. Beacham, (1993) FEMS Microbiology Letters, 114, 293-298).
  • Edwards et al. C. J. Edwards, D. J. Innes, D. M. Burns, I. R. Beacham, (1993) FEMS Microbiology Letters, 114, 293-298.
  • 5′-nucleotidase activity of periplasmic proteins for IMP, GMP and AMP was measured. Activity producing 1 ⁇ mol of phosphoric acid per minute was defined as 1 unit.
  • W ⁇ ushA had completely lost the nucleotide decomposition ability
  • its growth was investigated in a minimal medium containing a nucleotide as a sole carbon source.
  • W3110 and W ⁇ ushA were cultured overnight at 37° C. in LB medium, then washed with physiological saline, added to 50 mL of M9 minimal medium (J. H. Miller, “A SHORT COURSE IN BACTERIAL GENETICS”, Cold Spring Harbor Laboratory Press, New York, 1992) containing 5.8 g/L of IMP or 6.7 g/L of GMP, and cultured at 37° C.
  • W3110 and W ⁇ ushA were cultured in M9 medium containing IMP or GMP as a sole carbon source, and RNA was extracted from the cells at a proliferation phase by using RNeasy mini Kit (produced by Qiagen).
  • the extracted RNA solution was added with MgCl 2 and DNaseI (Boeringer Mannheim) at final concentrations of 10 mM and 0.25 U/ml, respectively, to decompose contaminated genomic DNA, and the total RNA were then purified by phenol/chloroform extraction and ethanol precipitation.
  • a reverse transcription reaction was performed by using AMV reverse transcriptase (produced by Promega), dATP, dGTP, dTTP, [ ⁇ - 33 P]-dCTP (all produced by Amersham Pharmacia), and random primer pd(N) 6 (produced by Amersham Pharmacia) according to the instructions appended to Panorama E. coli Gene Arrays to prepare a cDNA probe.
  • the obtained cDNA probe was purified by using ProbeQuant (produced by Amersham Pharmacia).
  • genes of which expression amount were larger in W ⁇ ushA compared with W3110 when they were cultured in M9 medium containing IMP as a carbon source, and genes of which expression amount were larger in W ⁇ ushA compared with W3110 when they were cultured in M9 medium containing GMP as a carbon source were selected, respectively.
  • the change of the carbon source for the culture might cause variation of expression amounts of many genes, the number of selected genes was large, and it was difficult to confirm function of each gene. Therefore, as means for narrowing down the candidate genes, the following screening method was employed.
  • the target 5′-nucleotidase gene showed increased expression amount in both of the cultures utilizing IMP and GMP as the carbon source, a product of a ratio of expression amounts in W ⁇ ushA and W3110 (W ⁇ ushA/W3110) obtained when they were cultured with IMP as the carbon source and a ratio of expression amounts in W ⁇ ushA and W3110 (W ⁇ ushA/W3110) obtained when they were cultured with GMP as the carbon source was calculated, and a gene showing a large value for the product was searched for.
  • the genes that showed larger values of top 50 are shown in Table 2 (1-25th places) and Table 3 (26-50th places).
  • genes of which functions were unknown were selected as candidates that might have the 5′-nucleotidase activity. Since W ⁇ ushA could grow by decomposing extracellular nucleotides, it was expected that the target 5′-nucleotidase should migrate to periplasm and function therein. Therefore, from those genes of which functions were unknown, only those having a signal sequence required for transition of protein to periplasm were selected. By these screenings, the candidate genes were narrowed down to two kinds, b0220 (or o157) and yjbP.
  • b0220 was a gene reported as a gene of unidentified function designated as ykfE
  • yjbP was a gene reported as an acid phosphatase gene (aphA) (M. C. Thaller, S. Schippa, A. Bonci, S. Cresti, G. M. Rossolini, (1997) FEMS Micorobilogy Letters, 146, 191-198).
  • aphA fragment was cloned into pSTV28 at a cleavage site obtained with SalI and SphI to obtain pSTVaphA.
  • W ⁇ ushA was transformed with each of the plasmids prepared as described above, and cultured at 37° C. in LB medium containing 30 ⁇ g/mL of chloramphenicol.
  • the 5′-nucleotidase activity for IMP, GMP and AMP as a substrate in periplasm of cells in a proliferation phase was measured.
  • the aphA gene amplification provided marked increase of the 5′-nucleotidase activity compared with a strain harboring only the vector as shown in Table 4, and thus it was confirmed that the AphA protein had the activity.
  • the ykfE-amplified strain did not show significant increase of the activity, and thus it was determined that it did not have the 5′-nucleotidase activity.
  • Gene disruption was performed in W ⁇ ushA strain for aphA, which was expected to be a gene for the 5′-nucleotidase activity.
  • a fragment of the N-terminus region and fragment of the C-terminus region of aphA were amplified by PCR using the primers shown in SEQ ID NOS: 3 and 7 and the primers shown in SEQ ID NOS: 4 and 8, respectively, and purified by using Wizard PCR Preps.
  • the amplification reaction solutions in an amount of 1 ⁇ L each were mixed, added to a PCR reaction solution and subjected to crossover PCR (A. J. Link, D. Phillips, G. M.
  • W3110, W ⁇ ushA, W ⁇ aphA and W ⁇ ushA ⁇ aphA were each cultured at 37° C. in LB medium, and 5′-nucleotidase activity in periplasm of cells in a proliferation phase was measured. The results are shown in Table 5. Although the activity in W ⁇ aphA was reduced about by half compared with W3110, it still strongly remained, and it was considered that ushA contributed to it. On the other hand, the 5′-nucleotidase activity in the periplasm of W ⁇ ushA ⁇ aphA, which was a double-deficient strain, was further reduced and substantially eliminated.
  • the gene disruption was performed for ushA and aphA in an inosine producing strain of Escherichia coli.
  • inosine producing bacterium FADRaddeddyicPpgixapA (referred to as “I” hereinafter) described in International Patent Publication WO99/03988 was used.
  • the mutant purF gene fragment contained in the plasmid pKFpurFKQ mentioned in WO99/03988 was digested with BamHI and HindIII, then purified and ligated to pMW218 (produced by Nippon Gene) digested with the same enzymes.
  • the obtained plasmid pMWpurFKQ was introduced into the I strain.
  • the obtained strain, I/pMWpurFKQ became a strain having ability to accumulate about 2-3 g/L of inosine in culture broth.
  • the aforementioned strain FADRaddeddyicPpgixapA was a strain in which PRPP amidotransferase gene (purF), succinyl-AMP synthase gene (purA), purine nucleoside phosphorylase gene (deoD), purine repressor gene (purR), adenosine deaminase gene (add), 6-phosphogluconate dehydrase gene (edd), adenine deaminase gene (yicP), phosphoglucose isomerase gene (pgi) and xanthosine phosphorylase gene (xapA) were disrupted.
  • PRPP amidotransferase gene purF
  • succinyl-AMP synthase gene purA
  • purine nucleoside phosphorylase gene deoD
  • purine repressor gene purine repressor gene
  • adenosine deaminase gene add
  • pKFpurFKQ contained a mutant purF coding for PRPP amidotransferase in which the 326th lysine residue was replaced with a glutamine residue, and of which feedback inhibition by AMP and GMP was canceled (see International Patent Publication WO99/03988).
  • a ushA-single deficient strain I ⁇ ushA/pMWpurFKQ
  • aphA-single deficient strain I ⁇ aphA/pMWpurFKQ
  • ushA- and aphA-double deficient strain I ⁇ ushA ⁇ aphA/pMWpurFKQ
  • Refresh culture stored cells were inoculated, LB agar medium (added with necessary agents), 37° C., overnight.
  • Seed culture refreshed cells were inoculated, LB broth (added with necessary agents), 37° C., overnight.
  • Main culture seed culture broth was inoculated in an amount of 2%, MS medium (added with adenine and other agents as required), 37° C., 20 ml, in 500-ml volume Sakaguchi flask.
  • guanosine producing ability was imparted to the ushA- and aphA-double deficient strain obtained in Example 6, I ⁇ ushA ⁇ aphA/pMWpurFKQ. Impartation or enhancement of guanosine producing ability was attained by enhancing genes of enzymes catalyzing reactions from IMP to GMP.
  • the reaction converting IMP to XMP is catalyzed by IMP dehydrogenase encoded by guaA
  • the reaction converting XMP to GMP is catalyzed by GMP synthetase encoded by guaB, and it is known that these genes constitute an operon (guaBA) in Escherichia coli.
  • PCR was performed by using the primer shown in SEQ ID NOS: 9 and 10 to amplify guaBA operon of Escherichia coli.
  • the amplified fragment was purified, and the restriction enzyme sites formed on the both ends were digested with SacI and KpnI.
  • the digested fragment was ligated to pSTV28 similarly digested with SacI and KpnI, and a plasmid pSTVguaBA into which the guaBA gene was incorporated was selected.
  • This plasmid can coexist with the plasmid pMWpurFKQ harbored by I ⁇ ushA ⁇ aphA/pMWpurFKQ.
  • I ⁇ ushA ⁇ aphA/pMWpurFKQ strain was introduced into the I ⁇ ushA ⁇ aphA/pMWpurFKQ strain to obtain I ⁇ ushA ⁇ aphA/pMWpurFKQ/pSTVguaBA strain. Further, as a control, I ⁇ ushA ⁇ aphA/pMWpurFKQ/pSTV28 strain was prepared, which was introduced with the vector pSTV28.
  • inosine, IMP, guanosine and GMP accumulated in the culture broth were quantified for the I ⁇ ushA ⁇ aphA/pMWpurFKQ/pSTVguaBA strain and I ⁇ ushA ⁇ aphA/pMWpurFKQ/pSTV28 strain.
  • the results are shown in Table 7.
  • the culture time was prolonged due to the influence of the introduction of pSTV28, and it provided a result different from that of the I ⁇ ush ⁇ aphA/pMWpurFKQ/pSTVguaBA strain.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

Nucleoside 5'-phosphate ester is produced by culturing a bacterium belonging to the genus Escherichia having an ability to produce nucleoside 5'-phosphate ester, in which ushA gene and aphA gene do not function normally, in a medium to produce and accumulate nucleoside 5'-phosphate ester in the medium, and collecting the nucleoside 5'-phosphate ester from the medium.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention relates to a method for producing nucleotides by fermentation. Nucleotides such as nucleoside 5′-phosphate esters are useful as seasonings, drugs, raw materials thereof and so forth.
  • 2. Description of the Related Art
  • As methods for industrial production of nucleoside 5′-phosphate esters, there are known methods comprising producing nucleoside by fermentation and enzymatically phosphorylating the obtained nucleoside to obtain nucleoside 5′-phosphate ester.
  • On the other hand, methods of directly producing nucleoside 5′-phosphate esters by fermentation have also been proposed. For example, Japanese Patent Publication (Kokoku) No. 56-12438 discloses a method for producing 5′-guanylic acid, which comprises culturing a mutant strain of a bacterium belonging to the genus Bacillus showing adenine auxotrophy and resistance to decoyinine or methionine sulfoxide and having an ability to produce 5′-guanylic acid (guanosine 5′-monophosphate, also abbreviated as “GMP” hereinafter) and collecting GMP produced and accumulated in the medium. Further, there are several reports on deriving strains which produce 5′-inosinic acid (inosine 5′-monophosphate, also abbreviated as “IMP” hereinafter) from inosine producing strains of Bacillus subtilis (Magasanik, B. et al., J. Biol. Chem., 226, 339 (1957); Fujimoto, M., et al., Agr. Biol. Chem., 30, 605 (1966)). However, the production of nucleoside 5′-phosphate esters by direct fermentation generally suffers from insufficient yield, and it is not so practical compared with the aforementioned enzymatic methods.
  • As the reasons for the difficulty of IMP production by direct fermentation, there are mentioned bad cell permeability of IMP and quite ubiquitous distribution of degradative enzymes that decompose IMP (Nucleic Acid Fermentation, Edited by Aminosan Kakusan Shudankai, Kodansha Scientific, Japan). To overcome these obstacles, there has been attempted to delete nucleotide degradative activity. As degradative enzymes that decompose IMP into inosine, 5′-nucleotidase, acid phosphatase, alkaline phosphatase and so forth are conceived (Nucleic Acid Fermentation, supra). Further, the aforementioned Japanese Patent Publication No. 56-12438 also suggests that a bacterial strain showing high GMP yield can be obtained from a mutant strain showing reduced nucleotidase activity.
  • As a technique for producing nucleoside 5′-phosphate ester on an industrial level, a method of producing IMP by using a mutant strain of Brevibacterium ammoniagenes has been developed (Furuya et al., Appl. Microbiol., 16, 981 (1968)).
  • As described above, various studies have been made on the production of nucleoside 5′-phosphate esters by direct fermentation, and some successful examples are also known. However, there are many unknown points about nucleotide degradative enzymes, and it cannot be said that improvement of yield has been studied sufficiently. In particular, no example of production of nucleoside 5′-phosphate esters on a practical level has been known for bacteria belonging to the genus Escherichia.
    • SUMMARY OF THE INVENTION
  • The present invention was accomplished in view of the technical situation described above, and an object of the invention is to provide a method for producing nucleoside 5′-phosphate ester such as IMP using a bacterium belonging to the genus Escherichia.
  • The inventors of the present invention assiduously studied in order to achieve the aforementioned object. As a result, they found that a gene coding for 5′-nucleotidase other than the known gene existed in Escherichia coli, and successfully identified the gene. Further, they found that Escherichia coli having inosine producing ability or guanosine producing ability became to produce IMP or GMP, if the novel gene was disrupted in addition to the known 5′-nucleotidase gene. Thus, they accomplished the present invention.
  • That is, the present invention provides the followings.
  • (1) A method for producing nucleoside 5′-phosphate ester, comprising the steps of culturing a bacterium belonging to the genus Escherichia having an ability to produce nucleoside 5′-phosphate ester, in which ushA gene and aphA gene do not function normally, in a medium to produce and accumulate nucleoside 5′-phosphate ester in the medium, and collecting the nucleoside 5′-phosphate ester from the medium.
  • (2) The method for producing nucleoside 5′-phosphate ester according to (1), wherein mutations are introduced into the ushA gene and the aphA gene or these genes are disrupted so that they do not function normally.
  • (3) The method for producing nucleoside 5′-phosphate ester according to (1) or (2), wherein the nucleoside 5′-phosphate ester is selected from the group consisting of 5′-inosinic acid or 5′-guanylic acid.
  • (4) A bacterium belonging to the genus Escherichia having an ability to produce nucleoside 5′-phosphate ester, in which ushA gene and aphA gene are disrupted.
  • (5) The bacterium belonging to the genus Escherichia according to (4), wherein the nucleoside 5′-phosphate ester is selected from the group consisting of 5′-inosinic acid or 5′-guanylic acid.
  • (6) A method for searching for a 5′-nucleotidase gene affecting accumulation of nucleoside 5′-phosphate ester, comprising the steps of culturing a parent strain of microorganism and a derivative strain thereof in which a known 5′-nucleotidase is deleted in a minimal medium containing a first nucleoside 5′-phosphate ester as a sole carbon source and a minimal medium containing a second nucleoside 5′-phosphate ester as a sole carbon source to examine expression profiles of genes in the parent strain and the derivative strain,
  • calculating a product of a ratio of expression amounts of each gene in the parent strain and the derivative strain when they are cultured in a medium containing the first nucleoside 5′-phosphate ester as a carbon source and a ratio of expression amounts of each gene in the parent strain and the derivative strain when they are cultured in a medium containing the second nucleoside 5′-phosphate ester as a carbon source, and selecting one or more genes showing a larger value of the product.
  • (7) The method for searching for a 5′-nucleotidase gene according to (6), wherein the first and second nucleoside 5′-phosphate esters are 5′-inosinic acid and 5′-guanylic acid.
  • (8) The method for searching for a 5′-nucleotidase gene according to (6) or (7), further comprising the step of selecting a gene that can code for a signal sequence required for transition of a protein into periplasm from the selected genes.
  • According to the present invention, nucleoside 5′-phosphate ester such as IMP and GMP can be produced by direct fermentation using a bacterium belonging to the genus Escherichia.
    • Preferred Embodiments of the Invention
  • Hereafter, the present invention will be explained in detail.
  • <1> Search of an Unknown 5′-nucleotidase Gene
  • As a known 5′-nucleotidase of Escherichia coli, UDP-sugar hydrolase (UshA), which is a product of the ushA gene (GenBank accession X03895), is known. It has been known that the enzyme has 5′-nucleotidase activity that catalyzes dephosphorylation of nucleoside 5′-phosphate such as AMP, GMP, IMP and XMP to produce a corresponding nucleoside (H. C. Neu, (1967) Journal of Biological Chemistry, 242, 3896-3904; A. Cowman, I. R. Beacham, (1980) Gene, 12, 281-286).
  • The inventors of the present invention disrupted the ushA gene of Escherichia coli W3110 strain, and examined its influence on the nucleotide decomposing ability. The 5′-nucleotidase activity in periplasm of the ushA gene-disrupted W3110 strain (WΔushA) was markedly reduced compared with the W3110 strain. However, when growth of the WΔushA strain was investigated in a minimal medium containing nucleoside-5′-phosphate as a sole carbon source, this strain could grow. Therefore, it was considered that the nucleotide decomposing ability is not completely lost by the disruption of only ushA. Furthermore, when nucleoside-5′-phosphate was used as a sole carbon source, start of the growth was retarded. Therefore, it was expected that there existed another 5′-nucleotidase that was induced when UshA did not function.
  • The inventor of the present invention attempted to search for an unknown 5′-nucleotidase gene based on the aforementioned findings, and found that a product of a gene reported as an acid phosphatase gene (aphA) (M. C. Thaller, S. Schippa, A. Bonci, S. Cresti, G. M. Rossolini, (1997) FEMS Microbilogy Letters, 146, 191-198, GenBank accession X86971) or yjbP (GenBank accession AAC77025) had the 5′-nucleotidase activity.
  • A gene coding for such a 5′-nucleotidase that affects the accumulation of nucleoside 5′-phosphate as described above can be searched for as follows.
  • First, a microbial parent strain and a derivative strain thereof in which a known 5′-nucleotidase is deleted are cultured in a minimal medium containing a first nucleoside 5′-phosphate ester or a second nucleoside 5′-phosphate ester such as IMP or GMP as a sole carbon source. When the microorganism is Escherichia coli, the known 5′-nucleotidase may be the aforementioned UshA.
  • Subsequently, gene expression profiles of these strains are investigated. Specifically, a ratio of expression amounts in the wild strain and the derivative strain is investigated for each gene.
  • Then, a product of a ratio of expression amounts of a gene in the parent strain and the derivative strain when they are cultured in a medium containing the first nucleoside 5′-phosphate as a carbon source and a ratio of expression amounts of the gene in the parent strain and the derivative strain when they are cultured in a medium containing the second nucleoside 5′-phosphate as a carbon source is calculated for each gene, and one or more genes showing a larger value of the product are selected.
  • Although the method for gene expression profiling is not particularly limited, the DNA array method (H. Tao, C. Bausch, C. Richmond, F. R. Blattner, T. Conway, (1999) Journal of Bacteriology, 181, 6425-6440) can be mentioned, for example.
  • From the aforementioned selected genes, target genes can be further narrowed down by selecting genes that may code a signal sequence required for transition of protein to periplasm. This is because it is expected that the target 5′-nucleotidase transits to periplasm and function therein.
  • As for Escherichia coli, as shown in the examples mentioned later, two kinds of genes, b0220 (also referred to as o157) and yjbP, were selected. Among these genes, yjbP was an acid phosphatase gene (aphA). On the other hand, b0220 was a gene of which function was unidentified, which was designated as ykfE. When these genes were amplified in Escherichia coli, remarkable increase of 5′-nucleotidase activity was not observed in the ykfE gene-amplified strain, whereas remarkable increase of 5′-nucleotidase activity was observed in the aphA gene-amplified strain. Thus, it was confirmed that the aphA gene product (AphA) had the 5′-nucleotidase activity. In this way, aphA was found as a gene coding for 5′-nucleotidase that affected the accumulation of nucleoside 5′-phosphate.
  • <2> Bacterium Belonging to the Genus Escherichia of the Present Invention
  • The Bacterium belonging to the genus Escherichia of the present invention is a bacterium belonging to the genus Escherichia having an ability to produce nucleoside 5′-phosphate, in which the ushA gene and the aphA gene do not function normally. The Bacterium belonging to the genus Escherichia itself is not particularly limited so long as it is a microorganism belonging to the genus Escherichia such as Escherichia coli. However, specifically, those mentioned in the reference of Neidhardt et al. (Neidhardt, F. C. et al., Escherichia coli and Salmonella Typhimurium, American society for Microbiology, Washington D.C., 1208, Table 1) can be used.
  • The Bacterium belonging to the genus Escherichia of the present invention can be obtained by, for example, breeding a mutant strain or genetic recombinant strain in which the ushA gene and the aphA gene do not normally function using a Bacterium belonging to the genus Escherichia having purine nucleoside producing ability as a parent strain. Further, the Bacterium belonging to the genus Escherichia of the present invention can also be obtained by breeding similar to the breeding of purine nucleoside producing strain using a strain in which the ushA gene and the aphA gene do not normally function as a parent strain.
  • Examples of bacteria belonging to the genus Escherichia having purine nucleoside producing ability include bacteria belonging to the genus Escherichia having an ability to produce inosine, guanosine, adenosine, xanthosine, purine riboside, 6-methoxypurine riboside, 2,6-diaminopurine riboside, 6-fluoropurine riboside, 6-thiopurine riboside, 2-amino-6-thiopurine riboside, mercaptoguanosine or the like. By breeding a mutant strain or genetic recombinant strain in which the ushA gene and the aphA gene do not normally function using these Escherichia bacteria having purine nucleoside producing ability as a parent strain, bacteria belonging to the genus Escherichia having an ability to produce nucleoside 5′-phosphate ester corresponding to each purine nucleoside can be obtained.
  • The purine nucleoside producing ability referred to in the present invention means an ability to produce and accumulate a purine nucleoside in a medium. Further, the expression of “having purine nucleoside producing ability” means that the microorganism belonging to the genus Escherichia produces and accumulates a purine nucleoside in a medium in an amount larger than that obtained with a wild strain of E. coli, for example, the W3110 strain.
  • Further, the ability to produce nucleoside 5′-phosphate ester means an ability to produce and accumulate nucleoside 5′-phosphate ester in a medium. Furthermore, the expression of “having purine nucleoside producing ability” means that the microorganism belonging to the genus Escherichia produces and accumulates a purine nucleoside in a medium in an amount larger than that obtained with a wild strain of E. coli, for example, the W3110 strain, and it preferably means that the microorganism produces and accumulates nucleoside 5′-phosphate ester in an amount of 100 mg/L or more, more preferably 500 mg/L or more, further preferably 1000 mg/L or more, when it is cultured under the conditions mentioned in Example 6 described later.
  • Bacteria belonging to the genus Escherichia having purine nucleoside producing ability are detailed in International Patent Publication WO99/03988, for example. More specifically, there can be mentioned the Escherichia coli FADRaddG-8-3::KQ strain (purFKQ, purA−, deoD−, purR−, add−, gsk−) described in the above international patent publication. This strain harbors a mutant purF coding for PRPP amidotransferase of which feedback inhibition by AMP and GMP is desensityzed, and in which the lysine residue at a position of 326 is replaced with a glutamine residue, and a succinyl-AMP synthase gene (purA), purine nucleoside phosphorylase gene (deoD), purine repressor gene (purR), adenosine deaminase gene (add), and inosine/guanosine kinase gene (gsk) are disrupted. This strain given with a private number of AJ13334 was deposited on Jun. 24, 1997 at the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry (currently, the independent administrative corporation, National Institute of Advanced Industrial Science and Technology, International Patent Organism Depositary) (Chuo Dai-6, 1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, postal code: 305-5466) as an international deposit under the provisions of the Budapest treaty, and received an accession number of FERM BP-5993. This strain has an ability to produce inosine and guanosine. Further, the strain obtained by introducing a plasmid containing a mutant purF gene into the FADRaddeddyicPpgixapA strain, which was constructed as described in the Example to be mentioned later, can also be suitably used as an inosine producing bacterium. Guanosine producing ability can be enhanced by introducing the guaA and guaB genes that encode IMP dehydrogenase and GMP synthetase, respectively, into an inosine producing bacterium. In the present invention, the bacterial strain is not limited to the aforementioned strains, and any strains having purine nucleoside producing ability can be used without any particular limitation.
  • A mutant strain or genetic recombinant strain in which the ushA gene and the aphA gene do not function normally can be obtained by modifying the genes so that the activities of 5′-nucleotidases that are the products of the genes should be decreased or deleted, or transcription of these genes should be decreased or eliminated. Such a microorganism can be obtained by, for example, replacing the ushA gene and the aphA gene on the chromosome with an ushA gene and aphA gene that do not function normally (also referred to as “disrupted ushA gene” and “disrupted aphA gene” hereinafter) by homologous recombination utilizing a genetic recombination method (Experiments in Molecular Genetics, Cold Spring Harbor Laboratory press (1972); Matsuyama, S. and Mizushima, S., J. Bacteriol., 162, 1196 (1985)).
  • In homologous recombination, a plasmid or the like having a sequence showing homology to a sequence on a chromosome is introduced into a bacterial cell. Then, recombination occurs at a certain frequency at a position of the homologous sequence so that the whole introduced plasmid is incorporated into the chromosome. When recombination is further caused thereafter at the position of the homologous sequence, the plasmid is again removed from the chromosome. At this time, depending on the position of the recombination, the disrupted gene may remain on the chromosome, and the original normal gene may be removed together with the plasmid. By selecting such a bacterial strain, a strain in which the normal ushA gene or aphA gene on the chromosome is replaced with the disrupted ushA gene or the disrupted aphA gene can be obtained.
  • A gene disruption technique based on such homologous recombination has already been established, and a method utilizing a linear DNA, a method utilizing a temperature sensitive plasmid and so forth can be used. The disruption of the ushA gene and the aphA gene can also be performed by using a plasmid containing an ushA gene or aphA gene internally inserted with a marker gene such as a drug resistance gene, which cannot replicate in a target microbial cell. That is, in a transformant that was transformed with the aforementioned plasmid and hence acquired drug resistance, the marker gene is incorporated into the chromosomal DNA. Since it is highly probable that this marker gene is incorporated into the chromosome by homologous recombination of the ushA gene or aphA gene sequences located on the both ends of the marker gene with those genes on the chromosome, a gene-disrupted strain can be selected efficiently.
  • The disrupted ushA gene and the disrupted aphA gene used for the gene disruption can be obtained by, specifically, deleting a certain region of these genes by digestion with a restriction enzyme and ligation, inserting another DNA fragment (marker gene etc.) into these genes, or introducing substitution, deletion, insertion, addition or inversion of one or more nucleotides into a nucleotide sequence of coding region, promoter region or the like of the ushA gene or the aphA gene by the site-specific mutagenesis (Kramer, W. and Frits, H. J., Methods in Enzymology, 154, 350 (1987)) or treatment with a chemical agent such as sodium hyposulfite or hydroxylamine (shortie, D. and Nathans, D., Proc. Natl. Acad. Sci. U.S.A., 75, 270 (1978)) so that activity of the encoded repressor should be decreased or deleted, or transcription of the ushA gene or the aphA gene should be decreased or eliminated. Among these embodiments, the method of deleting a certain region of the ushA gene or aphA by digestion with a restriction enzyme and ligation and the method of inserting another DNA fragment into these genes are preferred in view of certainty and stability of the methods. The order of the gene disruption of the ushA gene and the aphA gene is not particularly limited, and either one may be disrupted first.
  • The nucleotide sequences of the ushA gene and the aphA genes themselves are known, and hence they can be easily obtained by PCR or hybridization based on such nucleotide sequences. For example, the ushA gene can be obtained from chromosome DNA of Escherichia coli by PCR using the primers shown in SEQ ID NOS: 1 and 2, for example. Further, the N-terminal region of the aphA gene can be obtained by PCR using the primers shown in SEQ ID NOS: 3 and 7, and the C-terminal region of the same can be obtained by PCR using the primers shown in SEQ ID NOS: 4 and 8.
  • Whether the target gene has been disrupted or not can be confirmed by analyzing the gene on a chromosome by Southern blotting or PCR.
  • <3> Method for Producing nucleoside 5′-phosphate ester
  • Nucleoside 5′-phosphate ester can be produced by culturing a bacterium belonging to the genus Escherichia having an ability to produce nucleoside 5′-phosphate ester, in which the ushA gene and the aphA gene do not function normally, in a medium to produce and accumulate nucleoside 5′-phosphate ester in the medium, and collecting the nucleoside 5′-phosphate ester from the medium.
  • The medium may be a usual medium containing a carbon source, nitrogen source, inorganic ions, and other organic components, if needed. As the carbon source, there can be used saccharides such as glucose, lactose, galactose, fructose, arabinose, maltose, xylose, trehalose, ribose and starch hydrolysate, alcohols such as glycerol, mannitol and sorbitol, organic acids such as gluconic acid, fumaric acid, citric acid and succinic acid and so forth.
  • As the nitrogen source, there can be used inorganic ammonium salts such as ammonium sulfate, ammonium chloride, and ammonium phosphate, organic nitrogen such as soybean hydrolysate, ammonia gas, aqueous ammonia and so forth.
  • As the organic trace nutrients, it is desirable to add required substances including vitamins such as vitamin B1, nucleic acids such as adenine and RNA or yeast extract in a suitable amount. In addition to these, a small amount of potassium phosphate, magnesium sulfate, iron ions, manganese ions and so forth are added as required.
  • Culture is preferably carried out under an aerobic condition for 16-72 hours. The culture temperature is controlled to be 30° C. to 45° C., and pH is controlled to be 5 to 8 during the culture. Inorganic or organic, acidic or alkaline substances as well as ammonia gas and so forth can be used for pH adjustment.
  • Collection of nucleoside 5′-phosphate ester from fermented liquor is usually carried out by a combination of an ion exchange resin method, a precipitation method and other known techniques.
    • BEST MODE FOR CARRYING OUT THE INVENTION
  • The present invention will be further specifically explained hereinafter with reference to the following examples.
    • EXAMPLE 1 Effect of ushA Disruption on nucleotide Production of Escherichia coli
  • <1> Construction of ushA-Disrupted Strain
  • From genomic DNA of the Escherichia coli W3110 strain, a ushA gene fragment was amplified by PCR. The genomic DNA was extracted by using RNA/DNA maxi Kit (produced by Qiagen). PCR was performed by using the primers shown in SEQ ID NOS: 1 and 2 and Pyrobest DNA Polymerase (produced by Takara Shuzo) according to the instruction appended to the polymerase. After PCR, the amplified DNA fragments were purified by using Wizard PCR Preps (produced by Promega). After digestion with restriction enzymes SphI and SalI (produced by Takara Shuzo), the purified DNA fragments were subjected to a phenol/chloroform treatment and ethanol precipitation. pHSG397 (produced by Takara Shuzo) similarly digested with SphI and SalI was ligated by using DNA ligation Kit Ver.2 (produced by Takara Shuzo). Competent cells of JM109 (produced by Takara Shuzo) were transformed with the above ligation mixture, and plated on an LB agar plate containing 30 μg/mL of chloramphenicol (produced by Sigma) (LB+chloramphenicol plate). After culturing at 37° C. overnight, grown colonies were cultured in LB medium containing 30 μg/mL of chloramphenicol at 37° C. in a test tube, and a plasmid was extracted using an automatic plasmid extractor, PI-50 (produced by Kurabo Industries). The obtained plasmid was designated as pHSGushA.
  • Then, an HpaI fragment was removed from the ushA gene contained in pHSGushA as follows. pHSGushA was digested with a restriction enzyme HpaI (produced by Takara Shuzo), subjected to a phenol/chloroform treatment and ethanol precipitation, and ligated by using DNA Ligation Kit Ver.2. JM109 was transformed with this ligation solution, and a plasmid was extracted from emerged colonies. The obtained plasmid was digested with SphI and SalI, and subjected to agarose gel electrophoresis to select a plasmid containing an inserted target fragment in which the HpaI digestion fragment was deleted from the ushA gene region.
  • The obtained plasmid fragment and a fragment obtained by digesting the temperature sensitive plasmid pMAN997 described in International Patent Publication WO99/03988 with SphI and SalI were ligated. JM109 was transformed with the ligation solution, and colonies were selected at 30° C. on an LB agar plate containing 50 μg/mL of ampicillin (produced by Meiji Seika Kaisha) (LB+ampicillin plate). The colonies were cultured in LB medium containing 50 μg/mL of ampicillin at 30° C. in a test tube, and plasmids were extracted. A plasmid from which a fragment of a desired length could be obtained by digestion with SphI and SalI was used as a plasmid for ushA disruption, pMANΔushA. The above pMAN997 was obtained by exchanging VspI-HindIII fragments of pMAN031 (J. Bacteriol., 162, 1196 (1985)) and pUC19 (produced by Takara Shuzo).
  • The W3110 strain was transformed with pMANΔushA, and colonies were selected on an LB+ampicillin plate at 30° C. The selected clones were cultured at 30° C. overnight as liquid culture. The culture broth was diluted 10−3times, and inoculated on an LB+ampicillin plate, and colonies were selected at 42° C. The selected clones were applied and spread on an LB+ampicillin plate, and cultured at 30° C. Then, ⅛ of the cells on the plate were suspended in 2 mL of LB medium, and cultured at 42° C. for 4 to 5 hours with shaking. The cells diluted 10−5 times were seeded on an LB plate, and several hundreds of colonies among the obtained colonies were inoculated on an LB plate and LB+ampicillin plate, and growth was confirmed to select ampicillin sensitive strains. Colony PCR was performed for several strains among the ampicillin sensitive strains to confirm the deletion of ushA gene. In this way, an ushA-disrupted strain derived from E. coli W3110, WΔushA, was obtained.
  • <2> Measurement of 5′-nucleotidase and nucleotide Assimilation Culture
  • W3110 and WΔushA were cultured at 37° C. in LB medium, and periplasm was extracted from cells in a proliferation phase according to the method of Edwards et al. (C. J. Edwards, D. J. Innes, D. M. Burns, I. R. Beacham, (1993) FEMS Microbiology Letters, 114, 293-298). By using the procedure described in the above reference, 5′-nucleotidase activity of periplasmic proteins for IMP, GMP and AMP was measured. Activity producing 1 μmol of phosphoric acid per minute was defined as 1 unit. As a result, the periplasmic 5′-nucleotidase activity of WΔushA was markedly decreased compared with W3110 as shown in Table 1.
    TABLE 1
    Periplasmic 5′-nucleotidase activity (Unit/mg of protein)
    Substrate
    Strain IMP GMP AMP
    W3110 14.0 10.8 14.2
    WΔushA 0.21 0.16 0.03
  • In order to confirm whether WΔushA had completely lost the nucleotide decomposition ability, its growth was investigated in a minimal medium containing a nucleotide as a sole carbon source. W3110 and WΔushA were cultured overnight at 37° C. in LB medium, then washed with physiological saline, added to 50 mL of M9 minimal medium (J. H. Miller, “A SHORT COURSE IN BACTERIAL GENETICS”, Cold Spring Harbor Laboratory Press, New York, 1992) containing 5.8 g/L of IMP or 6.7 g/L of GMP, and cultured at 37° C. After a suitable time had passed, the culture broth was collected and its absorbance at 600 nm was measured by using a spectrophotometer DU640 (produced by Beckman). Although the growth of WΔushA degraded in M9 medium containing IMP or GMP as a carbon source, it could grow in such a medium. This suggested that the nucleotide degradative ability was not completely lost by the disruption of only ushA. Further, since the start of growth was retarded, existence of another 5′-nucleotidase was expected, which was induced when UshA did not function.
    • EXAMPLE 2 Search of Novel 5′-nucleotidase Gene
  • It was considered that the 5′-nucleotidase gene predicted in Example 1 was more strongly expressed in WΔushA compared with W3110 when they were cultured in M9 medium containing IMP or GMP as a carbon source. In order to identify the 5′-nucleotidase considered to function in WΔushA, gene expression profiles of W3110 and WΔushA cultured in M9 medium containing IMP or GMP as a carbon source were compared.
  • For comparison of gene expression profiles, the DNA array method (H. Tao, C. Bausch, C. Richmond, F. R. Blattner, T. Conway, (1999) Journal of Bacteriology, 181, 6425-6440) was used. Panorama E. coli Gene Arrays (produced by Sigma Genosis) is a DNA array composed of a nylon membrane spotted with amplified DNA fragment of 4290 genes of E. coli, and mRNA expression amounts of the total genes of E. coli can be comprehensively analyzed at once by using it.
  • W3110 and WΔushA were cultured in M9 medium containing IMP or GMP as a sole carbon source, and RNA was extracted from the cells at a proliferation phase by using RNeasy mini Kit (produced by Qiagen). The extracted RNA solution was added with MgCl2 and DNaseI (Boeringer Mannheim) at final concentrations of 10 mM and 0.25 U/ml, respectively, to decompose contaminated genomic DNA, and the total RNA were then purified by phenol/chloroform extraction and ethanol precipitation. A reverse transcription reaction was performed by using AMV reverse transcriptase (produced by Promega), dATP, dGTP, dTTP, [α-33P]-dCTP (all produced by Amersham Pharmacia), and random primer pd(N)6 (produced by Amersham Pharmacia) according to the instructions appended to Panorama E. coli Gene Arrays to prepare a cDNA probe. The obtained cDNA probe was purified by using ProbeQuant (produced by Amersham Pharmacia).
  • By using the cDNA probe obtained above, hybridization and washing were performed according to the instruction appended to Panorama E. coli Gene Arrays. The membrane was enclosed in a hybridization bag, and brought into contact with an imaging plate (produced by Fuji Photo Film) for 48 hours, and an image was captured by using FLA3000G (produced by Fuji Photo Film). Concentration of each spot was quantified by using image analysis software, AIS (produced by Imaging Research), and ratio of each spot concentration with respect to the sum of the total spot concentrations on the same membrane was represented for every membrane. Increase and decrease of gene expression was investigated by comparing values of this ratio for each gene.
  • In this way, genes of which expression amount were larger in WΔushA compared with W3110 when they were cultured in M9 medium containing IMP as a carbon source, and genes of which expression amount were larger in WΔushA compared with W3110 when they were cultured in M9 medium containing GMP as a carbon source were selected, respectively. However, since the change of the carbon source for the culture might cause variation of expression amounts of many genes, the number of selected genes was large, and it was difficult to confirm function of each gene. Therefore, as means for narrowing down the candidate genes, the following screening method was employed.
  • Since it was considered that the target 5′-nucleotidase gene showed increased expression amount in both of the cultures utilizing IMP and GMP as the carbon source, a product of a ratio of expression amounts in WΔushA and W3110 (WΔushA/W3110) obtained when they were cultured with IMP as the carbon source and a ratio of expression amounts in WΔushA and W3110 (WΔushA/W3110) obtained when they were cultured with GMP as the carbon source was calculated, and a gene showing a large value for the product was searched for. The genes that showed larger values of top 50 are shown in Table 2 (1-25th places) and Table 3 (26-50th places). Among these, genes of which functions were unknown were selected as candidates that might have the 5′-nucleotidase activity. Since WΔushA could grow by decomposing extracellular nucleotides, it was expected that the target 5′-nucleotidase should migrate to periplasm and function therein. Therefore, from those genes of which functions were unknown, only those having a signal sequence required for transition of protein to periplasm were selected. By these screenings, the candidate genes were narrowed down to two kinds, b0220 (or o157) and yjbP.
  • When these genes were investigated, it was found that b0220 was a gene reported as a gene of unidentified function designated as ykfE, and yjbP was a gene reported as an acid phosphatase gene (aphA) (M. C. Thaller, S. Schippa, A. Bonci, S. Cresti, G. M. Rossolini, (1997) FEMS Micorobilogy Letters, 146, 191-198).
    TABLE 2
    Gene expression profiles observed in W3110 and WΔushA
    when they were cultured in M9 medium containing IMP
    or GMP as carbon source (1-25th places)
    IMP expression GMP expression
    Ratio (I) ratio (G) I × G Gene
    11.3 5.5 61.7 pyrB
    3.5 7.3 25.2 malE
    4.5 2.0 9.1 pyrI
    3.6 2.2 8.0 udp
    3.9 2.0 7.9 deoD
    2.8 2.6 7.2 yeiN
    1.9 3.7 7.2 lamB
    5.1 1.2 6.0 b0220 (o157)
    3.5 1.7 5.9 DeoA
    2.1 2.7 5.5 YeiC
    2.1 2.6 5.4 tsx
    3.0 1.8 5.3 b1036 (o173)
    4.2 1.2 4.9 DeoC
    2.3 2.1 4.8 NupC
    2.4 2.0 4.8 FadB
    2.1 2.3 4.8 YejD
    1.5 3.2 4.8 MalF
    1.9 2.3 4.4 CirA
    2.6 1.7 4.3 CarA
    1.5 2.9 4.2 LivJ
    3.2 1.3 4.0 TalB
    0.9 4.5 4.0 FliD
    1.5 2.6 4.0 MalM
    1.6 2.4 3.9 DppA
    1.0 4.0 3.8 FliC
  • TABLE 3
    Gene expression profiles observed in W3110 and WΔushA
    when they were cultured in M9 medium containing IMP
    or GMP as carbon source (26-50th places)
    IMP expression GMP expression
    Ratio (I) Ratio (G) I × G Gene
    0.8 4.4 3.7 CheA
    2.8 1.3 3.7 DeoB
    1.3 2.7 3.6 GlpK
    2.1 1.7 3.5 b2341 (f714)
    1.8 1.8 3.3 YeiK
    2.8 1.2 3.3 Cdd
    2.0 1.6 3.2 b2673 (o81)
    1.8 1.7 3.1 YeiP
    1.9 1.7 3.1 YeiR
    0.9 3.3 3.0 MotB
    3.1 1.0 3.0 YafP
    2.0 1.5 3.0 bO221 (f826)
    1.6 1.8 2.9 yjbP
    0.7 4.0 2.9 tap
    1.9 1.5 2.9 pyrH
    1.5 1.9 2.8 sseA
    1.8 1.6 2.8 ybeK
    0.8 3.3 2.7 flgN
    1.9 1.4 2.7 glnA
    2.0 1.3 2.7 ygaD
    2.3 1.2 2.7 entE
    1.7 1.6 2.6 yafY
    1.9 1.4 2.6 nupG
    1.8 1.7 2.6 fepA
    1.2 2.2 2.6 b3524
    (hypothetical)
    • EXAMPLE 3 Evaluation of Candidate Genes by Gene Amplification
  • Strains in which the candidate genes obtained in Example 2, ykfE and aphA, were each amplified were prepared to investigate the influence of the gene amplification on the 5′-nucleotidase activity. The gene fragments of ykfE and aphA were amplified by using the primers shown in SEQ ID NOS: 3 and 4, and the primers shown in SEQ ID NOS: 5 and 6, respectively. The ykfE fragment was cloned into a vector pSTV28 (produced by Takara Shuzo) at a cleavage site obtained with restriction enzymes SalI and PstI (produced by Takara Shuzo) to obtain pSTVykfE. Further, the aphA fragment was cloned into pSTV28 at a cleavage site obtained with SalI and SphI to obtain pSTVaphA. WΔushA was transformed with each of the plasmids prepared as described above, and cultured at 37° C. in LB medium containing 30 μg/mL of chloramphenicol. The 5′-nucleotidase activity for IMP, GMP and AMP as a substrate in periplasm of cells in a proliferation phase was measured. As a result, the aphA gene amplification provided marked increase of the 5′-nucleotidase activity compared with a strain harboring only the vector as shown in Table 4, and thus it was confirmed that the AphA protein had the activity. On the other hand, the ykfE-amplified strain did not show significant increase of the activity, and thus it was determined that it did not have the 5′-nucleotidase activity.
    TABLE 4
    5′-Nucleotidase activity in periplasm of aphA-
    and ykfE-amplified strains (U/mg of protein)
    Substrate
    Strain IMP GMP AMP
    WΔushA/pSTV 0.074 0.067 0.024
    WΔushA/pSTVykfE 0.15 0.15 0.067
    WΔushA/pSTVaphA 3.2 3.5 1.8
    • EXAMPLE 4 Introduction of aphA Disruption into WΔushA
  • Gene disruption was performed in WΔushA strain for aphA, which was expected to be a gene for the 5′-nucleotidase activity. A fragment of the N-terminus region and fragment of the C-terminus region of aphA were amplified by PCR using the primers shown in SEQ ID NOS: 3 and 7 and the primers shown in SEQ ID NOS: 4 and 8, respectively, and purified by using Wizard PCR Preps. The amplification reaction solutions in an amount of 1 μL each were mixed, added to a PCR reaction solution and subjected to crossover PCR (A. J. Link, D. Phillips, G. M. Church (1997) Journal of Bacteriology, 179, 6228-6237) using the primers shown in SEQ ID NOS: 3 and 4 to obtain an aphA gene fragment including deletion of its center portion of about 300 nucleotides. This fragment was inserted into an SalI-SphI cleavage site of temperature sensitive plasmid pMAN997 to obtain a plasmid pMANΔaphA for gene disruption. By using this plasmid for gene disruption, each aphA of W3110 and WΔushA was disrupted to obtain an aphA-deficient strain (WΔaphA) and ushA- and aphA-double deficient strain (WΔushAΔaphA).
    • EXAMPLE 5 Measurement of 5′-nucleotidase Activity and nucleotide Assimilation Culture of WΔushAΔaphA
  • W3110, WΔushA, WΔaphA and WΔushAΔaphA were each cultured at 37° C. in LB medium, and 5′-nucleotidase activity in periplasm of cells in a proliferation phase was measured. The results are shown in Table 5. Although the activity in WΔaphA was reduced about by half compared with W3110, it still strongly remained, and it was considered that ushA contributed to it. On the other hand, the 5′-nucleotidase activity in the periplasm of WΔushAΔaphA, which was a double-deficient strain, was further reduced and substantially eliminated.
    TABLE 5
    5′-Nucleotidase activity of W3110, WΔushA, WΔaphA,
    and WΔushAΔaphA (U/mg of protein)
    Substrate
    Strain IMP GMP AMP XMP
    W3110 14.0 10.9 14.2 8.7
    WΔaphA 5.8 4.1 6.0 3.9
    WΔushA 0.21 0.16 0.03 0.10
    WΔushAΔaphA 0.010 0.009 0.012 0.019
  • Furthermore, in order to investigate the nucleotide degradative ability of each strain, these strains were cultured in M9 medium containing IMP or GMP as a carbon source in flasks. While growth was observed for W3110, WΔaphA and WΔushA with both of the carbon sources with growth intensities in that order, growth was not observed for WΔushAΔaphA even though it was cultured for 300 hours, and thus it was revealed that it could not grow in M9 medium containing IMP or GMP as a sole carbon source. In this way, the ability to decompose extracellular nucleotide of E. coli W3110 was successfully deleted by double deficiency of ushA and aphA.
    • EXAMPLE 6 Gene Disruption for ushA and aphA in Inosine Producing Bacterium
  • In order to investigate the possibility of direct fermentation of IMP, the gene disruption was performed for ushA and aphA in an inosine producing strain of Escherichia coli. As the inosine producing bacterium, FADRaddeddyicPpgixapA (referred to as “I” hereinafter) described in International Patent Publication WO99/03988 was used. The mutant purF gene fragment contained in the plasmid pKFpurFKQ mentioned in WO99/03988 was digested with BamHI and HindIII, then purified and ligated to pMW218 (produced by Nippon Gene) digested with the same enzymes. The obtained plasmid pMWpurFKQ was introduced into the I strain. The obtained strain, I/pMWpurFKQ, became a strain having ability to accumulate about 2-3 g/L of inosine in culture broth.
  • The aforementioned strain FADRaddeddyicPpgixapA was a strain in which PRPP amidotransferase gene (purF), succinyl-AMP synthase gene (purA), purine nucleoside phosphorylase gene (deoD), purine repressor gene (purR), adenosine deaminase gene (add), 6-phosphogluconate dehydrase gene (edd), adenine deaminase gene (yicP), phosphoglucose isomerase gene (pgi) and xanthosine phosphorylase gene (xapA) were disrupted. Further, pKFpurFKQ contained a mutant purF coding for PRPP amidotransferase in which the 326th lysine residue was replaced with a glutamine residue, and of which feedback inhibition by AMP and GMP was canceled (see International Patent Publication WO99/03988).
  • By using the aforementioned plasmid pMANΔushA for ushA gene disruption and the plasmid pMANΔaphA for aphA gene disruption, a ushA-single deficient strain (IΔushA/pMWpurFKQ), aphA-single deficient strain (IΔaphA/pMWpurFKQ) and ushA- and aphA-double deficient strain (IΔushAΔaphA/pMWpurFKQ) were obtained.
  • Each of the aforementioned strains was evaluated for IMP producing ability. Medium, culture methods and analysis method for the evaluation of IMP producing ability are shown below.
  • [Base Medium: MS Medium]
    Final concentration
    Glucose 40 g/L (separately sterilized)
    (NH4)2SO4 16 g/L
    KH2PO4 1 g/L
    MgSO47H2O 1 g/L
    FeSO47H2O 0.01 g/L
    MnSO44H2O 0.01 g/L
    Yeast extract 8 g/L
    CaCO3 30 g/L (separately sterilized)

    [Culture Method]
  • Refresh culture: stored cells were inoculated, LB agar medium (added with necessary agents), 37° C., overnight.
  • Seed culture: refreshed cells were inoculated, LB broth (added with necessary agents), 37° C., overnight.
  • Main culture: seed culture broth was inoculated in an amount of 2%, MS medium (added with adenine and other agents as required), 37° C., 20 ml, in 500-ml volume Sakaguchi flask.
  • [Analysis Method]
  • In an amount of 500 μl of the culture broth was sampled in a time course, and centrifuged at 15,000 rpm for 5 minutes, and the supernatant was diluted 4 times with H2O and analyzed by HPLC.
  • Analysis Conditions:
    Column: Asahipak GS-220 (7.6 mm ID × 500 mm L)
    Buffer: 0.2 M NaH4PO4 (adjusted to pH 3.98 with
    phosphoric acid)
    Temperature: 55° C.
    Flow rate: 1.5 ml/min
    Detection: UV 254 nm
    Retention time (min)
    Inosine 16.40
    IMP 11.50
    Guanosine 19.67
    GMP 13.04
  • The results are shown in Table 6. In Table 6, results of two parallel experiments are indicated, respectively. It was demonstrated that IΔushAΔaphA accumulated about 1.0 g/L at most of IMP in the culture broth.
    TABLE 6
    Evaluation of ushA- and aphA-deficient strains of
    inosine producing bacterium by culture in flask
    Culture time Inosine IMP
    Strain (h) (g/L) (g/L)
    I/pMWpurFKQ 48 2.3 0
    48 2.3 0
    IΔushA/pMWpurFKQ 51 3.1 0
    51 2.9 0
    IΔaphA/pMWpurFKQ 51 3.6 0
    51 3.2 0
    IΔushAΔaphA/pMWpurFKQ 54 2.4 1.0
    54 2.6 0.6
    • EXAMPLE 7 Production of GMP by ushA- and aphA-Double Deficient Strain
  • In order to examine the possibility of GMP production by the present invention, guanosine producing ability was imparted to the ushA- and aphA-double deficient strain obtained in Example 6, IΔushAΔaphA/pMWpurFKQ. Impartation or enhancement of guanosine producing ability was attained by enhancing genes of enzymes catalyzing reactions from IMP to GMP. The reaction converting IMP to XMP is catalyzed by IMP dehydrogenase encoded by guaA, and the reaction converting XMP to GMP is catalyzed by GMP synthetase encoded by guaB, and it is known that these genes constitute an operon (guaBA) in Escherichia coli. Therefore, PCR was performed by using the primer shown in SEQ ID NOS: 9 and 10 to amplify guaBA operon of Escherichia coli. The amplified fragment was purified, and the restriction enzyme sites formed on the both ends were digested with SacI and KpnI. The digested fragment was ligated to pSTV28 similarly digested with SacI and KpnI, and a plasmid pSTVguaBA into which the guaBA gene was incorporated was selected. This plasmid can coexist with the plasmid pMWpurFKQ harbored by IΔushAΔaphA/pMWpurFKQ.
  • The aforementioned pSTVguaBA was introduced into the IΔushAΔaphA/pMWpurFKQ strain to obtain IΔushAΔaphA/pMWpurFKQ/pSTVguaBA strain. Further, as a control, IΔushAΔaphA/pMWpurFKQ/pSTV28 strain was prepared, which was introduced with the vector pSTV28.
  • According to the same culture methods and analysis method as in Example 6, inosine, IMP, guanosine and GMP accumulated in the culture broth were quantified for the IΔushAΔaphA/pMWpurFKQ/pSTVguaBA strain and IΔushAΔaphA/pMWpurFKQ/pSTV28 strain. The results are shown in Table 7. In the IΔushAΔaphA/pMWpurFKQ/pSTV28 strain used as a control, the culture time was prolonged due to the influence of the introduction of pSTV28, and it provided a result different from that of the IΔushΔaphA/pMWpurFKQ/pSTVguaBA strain. Guanosine could not be quantified, since its peaks overlapped with other peaks. On the other hand, it was demonstrated that the IΔushAΔaphA/pMWpurFKQ/pSTVguaBA strain accumulated about 0.1 g/L of GMP in the culture broth thanks to the introduction of guaBA.
    TABLE 7
    Culture of ushA- and aphA-deficient strain
    of inosine producing bacteria in flask
    Culture Inosine IMP Guanosine GMP
    Strain time (h) (g/L) (g/L) (g/L) (g/L)
    IΔushAΔaphA/ 78 9.7 0.4 —* 0.0
    pMWpurFKQ/pSTV28
    IΔushAΔaphA/ 78 3.4 0.2 1.1 0.1
    PMWpurFKQ/PSTVguaBA

    *indicates that quantification was not possible.

Claims (6)

1-8. (canceled)
9. A method for producing nucleoside 5′-phosphate ester, comprising the steps of culturing a bacterium belonging to Escherichia coli having an ability to produce nucleoside 5′-phosphate ester, in which expression of ushA gene and aphA gene is decreased as compared to a wild type strain by mutating or disrupting the ushA gene and the alpha gene, in a medium containing glucose or sucrose to produce and accumulate nucleoside 5′-phosphate ester in a medium by direct fermentation, and collecting the nucleoside 5′-phosphate ester is selected from the group consisting of inosine 5′-phosphate ester and guanosine 5′-phosphate ester.
10. The method according to claim 9, wherein the bacterium is further transformed with the mutant purF gene of Escherichia coli coding for PRPP amidotransferase in which the lysine residue at position 326 is replaced with a glutamine residue.
11. The method according to claim 10, wherein the bacterium is further transformed with a guaBA operon of Escherichia coli.
12. The method according to claim 9, wherein the nucleoside 5′-phosphate ester is inosine 5′-phosphate ester.
13. The method according to claim 9, wherein the nucleoside 5′-phosphate ester is guanosine 5′-phosphate ester.
US11/838,109 2000-07-05 2007-08-13 Method for producing nucleotide by fermentation Abandoned US20080026428A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/838,109 US20080026428A1 (en) 2000-07-05 2007-08-13 Method for producing nucleotide by fermentation

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000204260 2000-07-05
JP2000-204260 2000-07-05
US09/891,287 US20020098494A1 (en) 2000-07-05 2001-06-27 Method for producing nucleotide by fermentation
US10/798,339 US7575901B2 (en) 2000-07-05 2004-03-12 Method for producing nucleotide by fermentation
US11/838,109 US20080026428A1 (en) 2000-07-05 2007-08-13 Method for producing nucleotide by fermentation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/798,339 Division US7575901B2 (en) 2000-07-05 2004-03-12 Method for producing nucleotide by fermentation

Publications (1)

Publication Number Publication Date
US20080026428A1 true US20080026428A1 (en) 2008-01-31

Family

ID=18701553

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/891,287 Abandoned US20020098494A1 (en) 2000-07-05 2001-06-27 Method for producing nucleotide by fermentation
US10/798,339 Expired - Fee Related US7575901B2 (en) 2000-07-05 2004-03-12 Method for producing nucleotide by fermentation
US11/838,109 Abandoned US20080026428A1 (en) 2000-07-05 2007-08-13 Method for producing nucleotide by fermentation

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/891,287 Abandoned US20020098494A1 (en) 2000-07-05 2001-06-27 Method for producing nucleotide by fermentation
US10/798,339 Expired - Fee Related US7575901B2 (en) 2000-07-05 2004-03-12 Method for producing nucleotide by fermentation

Country Status (7)

Country Link
US (3) US20020098494A1 (en)
EP (1) EP1170370B1 (en)
KR (1) KR100779865B1 (en)
CN (1) CN1268758C (en)
BR (1) BR0102671A (en)
DE (1) DE60123334T2 (en)
ES (1) ES2272378T3 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110045543A1 (en) * 2008-02-25 2011-02-24 Takayuki Asahara Process for production of 5'-guanylic acid

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2271391C2 (en) * 2003-09-03 2006-03-10 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" METHOD FOR PREPARING INOSINE AND 5'-INOSINIC ACID BY FERMENTATION METHOD BY USING MICROORGANISMS BELONGING TO GENUS Escherichia
BRPI0509056A (en) * 2004-03-31 2007-08-21 Ajinomoto Kk bacteria belonging to the genus bacillus or genus escherichia, and methods for producing a purine nucleoside, for producing a purine nucleotide, and for producing 5'-guanylic acid
KR100664653B1 (en) * 2005-01-21 2007-01-04 씨제이 주식회사 Escherichia coli strain capable of converting XMP to GMP and having inactivated genes for GMP degradation and method for using the same
US20100210018A1 (en) * 2007-04-20 2010-08-19 Veritas Bio LLC Microbial host-vector complementation system
JP5636648B2 (en) * 2009-08-10 2014-12-10 味の素株式会社 Process for producing 5'-guanylic acid
CN102559667B (en) * 2011-12-31 2013-12-04 浙江工业大学 Application of deoxyinosine in oligodeoxynucleotide chain connection reaction
CN109803544A (en) * 2016-10-07 2019-05-24 天野酶制品株式会社 The manufacturing method of nucleic acid system seasoning
CN108441532A (en) * 2018-02-26 2018-08-24 安徽翠鸟生物技术有限公司 A kind of preparation method of uridine 5'-diphosphate
KR102006976B1 (en) * 2019-02-26 2019-08-06 씨제이제일제당 주식회사 Novel promoter and method for producing purine nucleotide using the same
CN112574934B (en) * 2020-10-12 2022-05-06 廊坊梅花生物技术开发有限公司 Engineering bacterium for high yield of guanosine as well as construction method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4024515Y1 (en) 1964-05-28 1965-08-20
JPS5420195A (en) * 1977-07-14 1979-02-15 Ajinomoto Co Inc Preparation of guanosine-5'-monophosphoric acid
JPS5612438A (en) 1979-07-13 1981-02-06 Mitsubishi Heavy Ind Ltd Drag suction-head for sludge dredging
KR100697552B1 (en) 1997-07-18 2007-03-21 아지노모토 가부시키가이샤 Process for producing purine nucleosides via fermentation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110045543A1 (en) * 2008-02-25 2011-02-24 Takayuki Asahara Process for production of 5'-guanylic acid
US8309329B2 (en) 2008-02-25 2012-11-13 Ajinomoto Co., Inc. Process for production of 5′-guanylic acid

Also Published As

Publication number Publication date
BR0102671A (en) 2002-03-05
EP1170370A2 (en) 2002-01-09
KR100779865B1 (en) 2007-11-27
KR20020004870A (en) 2002-01-16
DE60123334D1 (en) 2006-11-09
CN1268758C (en) 2006-08-09
ES2272378T3 (en) 2007-05-01
US20020098494A1 (en) 2002-07-25
CN1335403A (en) 2002-02-13
US20040152171A1 (en) 2004-08-05
EP1170370B1 (en) 2006-09-27
US7575901B2 (en) 2009-08-18
DE60123334T2 (en) 2007-09-06
EP1170370A3 (en) 2003-03-05

Similar Documents

Publication Publication Date Title
US20080026428A1 (en) Method for producing nucleotide by fermentation
EP1004663B1 (en) Process and microorganism for producing purine nucleosides via fermentation
US8298791B2 (en) Purine-derived substance-producing bacterium and a method for producing purine-derived substance
KR101250826B1 (en) Bacterium capable of producing purine substance, and process for production of purine substance
EP1733038B1 (en) Method for producing purine nucleosides and nucleotides by fermentation using bacterium belonging to the genus bacillus or escherichia
CN101432418B (en) Bacterium capable of producing purine substance, and process for production of purine substance
JP5488594B2 (en) Method for producing purine ribonucleoside and ribonucleotide
JP4352716B2 (en) Inosine-producing bacteria belonging to the genus Bacillus and a method for producing inosine
RU2333949C2 (en) STRAINS OF BACTERIA Bacillus subtilis AND Bacillus amyloliquefaciens - PRODUCENTS OF INOSINE AND METHOD FOR PRODUCING INOSINE USING THEM
JP4696404B2 (en) Method for producing nucleotides by fermentation
JP2003259861A (en) Purine nucleoside and method for producing nucleoside
JP2007075108A6 (en) Purine nucleoside producing bacteria and method for producing purine nucleoside
RU2403286C2 (en) Mutant phosphoribosyl pyrophosphate synthetase, dna coding said synthetase, bacterium coding said dna, method of producing purine nucleosides and method of producing purine nucelotides
RU2294962C2 (en) YdhL PROTEIN FROM Bacillus amyloliquefaciens, DNA FRAGMENT, BACTERIUM BELONGING TO GENUS Esherichia OR Bacillus AS PRODUCER OF PURINE NUCLEOSIDES, METHOD FOR PRODUCTION OF PURINE NUCLEOSIDES AND PURINE NUCLEOTIDES
JP2003325182A (en) Method for producing nucleoside-5&#39;-phosphate by fermentation method
JP2007075109A6 (en) Purine nucleoside producing bacteria and method for producing purine nucleoside
JP2007075109A (en) Purine nucleoside-producing strain and method for producing purine nucleoside

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION